Health Affairs April 13, 2018
Gillian Woollett, Bruce Pyenson

Perhaps the greatest turning point in the history of medicine occurred sometime in the 20th century when medical practice started doing more good than harm. While “First, do no harm” is always sound advice, it may not lead to optimal outcomes. Today’s regulators have succeeded fabulously in their charge by minimizing the risks of large-scale catastrophes such as the tragedies caused by the administering of sulphanilamide elixir, (an improperly prepared sulfanilamide medicine, which led to the 1938 Food, Drug, and Cosmetic Act) or thalidomide, but that has not saved us from the opioid epidemic. Meanwhile, critics complain that the Food and Drug Administration’s (FDA’s) deliberate processes delay approvals at the expense of patients. Is there an alternative that can better...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Pharma, Population Health Mgmt, Technology
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
Trump's Picks for Top Health Jobs Not Just Team of Rivals but 'Team of Opponents'
FDA updates definition of 'healthy'
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article